The Survey on Cellular and Tissue-Engineered Therapies in Europe in 2016 and 2017.

Cell- and Tissue-Based Therapy Europe Humans Mesenchymal Stem Cell Transplantation Mesenchymal Stem Cells Tissue Engineering
cellular therapy clinical trial regenerative medicine tissue engineering

Journal

Tissue engineering. Part A
ISSN: 1937-335X
Titre abrégé: Tissue Eng Part A
Pays: United States
ID NLM: 101466659

Informations de publication

Date de publication:
03 2021
Historique:
pubmed: 19 7 2020
medline: 16 10 2021
entrez: 19 7 2020
Statut: ppublish

Résumé

This report describes activity in Europe for the years 2016 and 2017 in the area of cellular and tissue-engineered therapies, excluding hematopoietic stem cell treatments for the reconstitution of hematopoiesis. It is the eighth of its kind and is supported by five established scientific organizations. In 2016 and 2017, a combined 234 teams from 29 countries responded to the cellular and engineered tissue therapy survey; 227 teams reported treating 8236 patients in these 2 years. Indications were categorized in

Identifiants

DOI: 10.1089/ten.TEA.2020.0092 PMID: 32680446 PMC: PMC8035930
pubmed: 32680446
doi: 10.1089/ten.TEA.2020.0092
pmc: PMC8035930
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

336-350

Références

Methods. 2016 Apr 15;99:135-44
pubmed: 26282436
Tissue Eng Part A. 2015 Jan;21(1-2):1-13
pubmed: 25425342
Tissue Eng Part A. 2010 Aug;16(8):2419-27
pubmed: 20184422
N Engl J Med. 2017 Mar 16;376(11):1047-1053
pubmed: 28296617
Stem Cells. 2017 Jan;35(1):256-264
pubmed: 27507787
Bone Marrow Transplant. 2018 Sep;53(9):1139-1148
pubmed: 29540849
Regen Med. 2012 Sep;7(5):721-32
pubmed: 22954441
Regen Med. 2009 Nov;4(6):835-53
pubmed: 19903003
Tissue Eng Part A. 2011 Sep;17(17-18):2221-30
pubmed: 21542713
MMWR Morb Mortal Wkly Rep. 2018 Dec 21;67(50):1397-1399
pubmed: 30571672
Tissue Eng Part A. 2014 Feb;20(3-4):842-53
pubmed: 24090467
Tissue Eng Part A. 2012 Nov;18(21-22):2268-79
pubmed: 22690805
Cytotherapy. 2018 Jan;20(1):1-20
pubmed: 28988692
Tissue Eng Part A. 2016 Jan;22(1-2):5-16
pubmed: 26653850
Bone Marrow Transplant. 2019 Oct;54(10):1575-1585
pubmed: 30728439

Auteurs

Max H P Gay (MHP)

Department of Biomedicine, Institute of Anatomy, University Hospital Basel, University of Basel, Basel, Switzerland.

Helen Baldomero (H)

EBMT Activity Survey Office, Division of Hematology, University Hospital Basel, University of Basel, Basel, Switzerland.

Dominique Farge-Bancel (D)

Unité de Médecine Interne, Maladies Auto-immunes et Pathologie Vasculaire, Université de Paris, Paris, France.
MATHEC, Centre de Référence des Maladies auto-immunes systémiques Rares d'Ile-de-France, Hôpital St-Louis, Paris, France.

Pamela G Robey (PG)

National Institute of Dental and Craniofacial Research, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, USA.

Scott Rodeo (S)

Orthopaedic Surgery, Weill Medical College of Cornell University, New York, New York, USA.
The Hospital for Special Surgery, New York, New York, USA.

Jakob Passweg (J)

EBMT Activity Survey Office, Division of Hematology, University Hospital Basel, University of Basel, Basel, Switzerland.

Magdalena Müller-Gerbl (M)

Department of Biomedicine, Institute of Anatomy, University Hospital Basel, University of Basel, Basel, Switzerland.

Ivan Martin (I)

Department of Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Thérapeutique › Biothérapie › Thérapie cellulaire et tissulaire › The Survey on Cellular and Tissue-Engineered...
questionsmedicales.fr › Régions géographiques › Europe › The Survey on Cellular and Tissue-Engineered...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › The Survey on Cellular and Tissue-Engineered...
questionsmedicales.fr › Procédures de chirurgie opératoire › Transplantation › Transplantation cellulaire › Transplantation de cellules souches › Transplantation de cellules souches mésenchymateuses › The Survey on Cellular and Tissue-Engineered...
questionsmedicales.fr › Cellules › Cellules souches › Cellules souches multipotentes › Cellules souches mésenchymateuses › The Survey on Cellular and Tissue-Engineered...
questionsmedicales.fr › Technologie, industrie et agriculture › Ingénierie › Bioingénierie › Ingénierie cellulaire › Ingénierie tissulaire › The Survey on Cellular and Tissue-Engineered...